Metformin is an antidiabetic agent that manages high blood sugar levels in type 2 diabetes patients. It reduces glucose absorption from the intestines, lowers liver glucose production, and improves insulin sensitivity. Metformin is recommended with dietary changes and exercise for better results.

Empagliflozin is used to treat type 2 diabetes. It works in the kidneys to prevent absorption of glucose (blood sugar). This helps lower the blood sugar level. Empagliflozin does not help patients who have insulin-dependent or type 1 diabetes.

Semaglutide injection is in a class of medications called incretin mimetics. It works by helping the pancreas to release the right amount of insulin when blood sugar levels are high. Insulin helps move sugar from the blood into other body tissues where it is used for energy.

MOUNJARO KwikPen contains the active ingredient tirzepatide. MOUNJARO KwikPen is a type of medicine called 'GIP and GLP-1 receptor agonists'. In adults, this medicine is used to help treat diabetes. In adults who are overweight or have obesity, this medicine is used to reduce weight or maintain weight loss.